These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 750129)
1. A comparison of the chemosensitivity of murine tumours in vivo and in cell culture. Bullen BR; Russell CW; Giles GR Clin Oncol; 1978 Sep; 4(3):265-72. PubMed ID: 750129 [No Abstract] [Full Text] [Related]
3. Proceedings: A comparison of tumour sensitivity to cytostatic agents during in vivo and in vitro culture. Bullen BR; Russell CW; Giles GR Br J Surg; 1976 Aug; 63(8):660. PubMed ID: 953488 [No Abstract] [Full Text] [Related]
4. A novel camptothecin analog with enhanced antitumor activity. Yount G; Yang Y; Wong B; Wang HJ; Yang LX Anticancer Res; 2007; 27(5A):3173-8. PubMed ID: 17970058 [TBL] [Abstract][Full Text] [Related]
5. [Evaluation of chemosensitivity in the 6-day subrenal capsule assay]. Inoue K Gan To Kagaku Ryoho; 1987 Aug; 14(8):2423-30. PubMed ID: 3619455 [TBL] [Abstract][Full Text] [Related]
6. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XXI. Leiter J; Abbott BJ; Schepartz SA Can Res Suppl; 1964 Dec; ():1093-353. PubMed ID: 5878218 [No Abstract] [Full Text] [Related]
7. [Type A adenocarcinoma grafted into C3H/he-M mice subjected to treatment with various antineoplastic agents. I. Biological study]. Flores JM; Gallego E; Castaño M; Gallego A Rev Esp Oncol; 1983; 30(3):337-59. PubMed ID: 6571377 [TBL] [Abstract][Full Text] [Related]
8. Screening data from the Cancer Chemotherapy National Service Center Screening Laboratories. XV. Leiter J; Abbott BJ; Bourke AR; Schepartz SA; Wodinsky I Cancer Res; 1963 Sep; 23(8 Pt 2):1483-729. PubMed ID: 5878214 [No Abstract] [Full Text] [Related]
9. Cyclophosphamide-adriamycin combination chemotherapy of transplantable murine tumors. Corbett TH; Griswold DP; Mayo JG; Laster WR; Schabel FM Cancer Res; 1975 Jun; 35(6):1568-73. PubMed ID: 1131824 [TBL] [Abstract][Full Text] [Related]
10. Nucleoside analogues: 8. Some isomers of B.3839, the original 5-fluorouracil/nitrosourea molecular combination, and their effect on colon, breast and lung tumours in mice. McElhinney RS; McCormick JE; Bibby MC; Double JA; Atassi G; Dumont P; Pratesi G; Radacic M Anticancer Drug Des; 1989 Jun; 4(1):1-20. PubMed ID: 2757750 [TBL] [Abstract][Full Text] [Related]
11. Design and evaluation of combination chemotherapy trials in experimental animal tumor systems. Corbett TH; Griswold DP; Wolpert MK; Venditti JM; Schabel FM Cancer Treat Rep; 1979 May; 63(5):799-801. PubMed ID: 455319 [No Abstract] [Full Text] [Related]
12. Glucan:inhibition of tumor growth and enhancement of survival in four syngeneic murine tumor models. Di Luzio NR; McNamee R; Browder WI; Williams D Cancer Treat Rep; 1978 Nov; 62(11):1857-66. PubMed ID: 728903 [No Abstract] [Full Text] [Related]
13. Nitrosoureas: a review of experimental antitumor activity. Schabel FM Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694 [TBL] [Abstract][Full Text] [Related]
14. [Experimental study on the establishment of a mammary adenocarcinoma MA--737 (author's transl)]. Sun WY; Ma KS; Guan JF Zhonghua Zhong Liu Za Zhi; 1980 Sep; 2(3):168-73. PubMed ID: 7227180 [No Abstract] [Full Text] [Related]
15. Antitumor efficacy of PD115934 (NSC 366140) against solid tumors of mice. LoRusso P; Wozniak AJ; Polin L; Capps D; Leopold WR; Werbel LM; Biernat L; Dan ME; Corbett TH Cancer Res; 1990 Aug; 50(16):4900-5. PubMed ID: 2165850 [TBL] [Abstract][Full Text] [Related]
16. [Analysis of chemosensitivity against a human breast cancer xenograft (MX-1) with the subrenal capsule assay in BDF1 mice]. Inoue K; Wang Y; Tada A; Ueno K; Kojima K; Ogawa M Gan To Kagaku Ryoho; 1985 Aug; 12(8):1644-50. PubMed ID: 4026333 [TBL] [Abstract][Full Text] [Related]
17. [Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II. Histopathological and ultrastructural study]. Flores JM; Gallego E; Castaño M; González JL Rev Esp Oncol; 1983; 30(3):361-78. PubMed ID: 6571378 [TBL] [Abstract][Full Text] [Related]
18. Body burden of cancer in relationship to therapeutic outcome: consideration of preclinical evidence. Griswold DP Cancer Treat Rep; 1986 Jan; 70(1):81-6. PubMed ID: 3943116 [No Abstract] [Full Text] [Related]
19. A modified screening system to select new cytostatic drugs. Kraemer HP; Sedlacek HH Behring Inst Mitt; 1984 May; (74):301-28. PubMed ID: 6383326 [No Abstract] [Full Text] [Related]
20. Approaches to combination chemotherapy in rat, mouse, and hamster tumors. Griswold DP; Dykes DJ; Kelley CA; Roberts BJ; Dominick CA Cancer Chemother Rep 2; 1974 Mar; 4(1):99-108. PubMed ID: 4524043 [No Abstract] [Full Text] [Related] [Next] [New Search]